425: Strive, Semler Scientific Merger Communication

Strive, Inc. and Semler Scientific, Inc. issued a communication regarding their proposed business combination, including cautionary statements about forward-looking information and associated risks.

Summary

• The communication was reposted on X.com by James Lavish, Board Member of Strive, Inc., on November 10, 2025.
• It pertains to Strive's proposed business combination with Semler Scientific, Inc.
• The filing includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties associated with the proposed transaction.
• It directs investors to additional information, including Strive's Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus, for comprehensive details.
• The document identifies Strive, Semler Scientific, and certain directors, executive officers, and employees as potential participants in the solicitation of proxies from Semler Scientific stockholders.
• It clarifies that the communication does not constitute an offer to sell or a solicitation of an offer to buy securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a neutral, procedural document primarily focused on providing cautionary statements and outlining risks associated with a proposed business combination, without expressing overly positive or negative sentiment about the transaction itself.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The filing includes forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific concerning the proposed transaction, its strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses. These statements are based on assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially.

Management Comments

• James Lavish, Board Member of Strive, Inc., reposted the communication on X.com on November 10, 2025.

Industry Context

This announcement is a standard procedural communication related to a proposed business combination, a common strategic move in various industries. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that at least one of the companies is engaged with or considering digital assets as part of its corporate strategy, reflecting a growing trend in corporate finance and treasury management across sectors.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in the section entitled 'TRANSACTIONS WITH RELATED PERSONS' included in Semler Scientific's definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's issuance of additional shares, requirement for Semler Scientific stockholders to approve the transaction, and potential changes in share price.
• Customers: Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Employees: Potential adverse reactions or changes to employee relationships resulting from the announcement or completion of the proposed transaction.

Next Steps

• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Recommendation

This filing is a procedural update and risk disclosure for a proposed merger, not a financial performance report. It highlights numerous uncertainties and risks inherent in such a transaction, including potential delays, integration difficulties, and dilution. Without further financial details or a clear strategic rationale beyond what's implied, a 'hold' recommendation is appropriate, advising investors to await more comprehensive information (like the definitive S-4) before making a definitive investment decision.

Keywords

Business Combination, Merger, Acquisition, SEC Filing, Form 425, Strive Inc, Semler Scientific, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury, Digital Assets